1. BIECK, P. R., CREMER, G., GLEITER, C. and ANTONIN K.H. (1983) Effect of the reversible MAO- inhibitor CGP 11 305 A on blood pressure response after oral tyramine. II. World Conference on Clinical Pharmacology and Therapeutics (1983) Washington.
2. BIECK, P.R., SCHICK, CH. (1984) Urinary Tyramine (TYR) and p-Hydroxyphenylacetic acid (HPAA) after oral TYR load as index of MAO inhibition. J. Pharm. Pharmacol. 36,Workshop Suppl. 69 W.
3. BIECK, P.R., ANTONIN K.H. and CREMER, G. (1984) Tyramine pressor effects of CGP 11 305 A in comparison to tranylcypromine after prolonged treatment of human volunteers. In Monoamine Oxidase and Disease (TIPTON, K.F., DOSTER, P. and BENEDETTI, M.S. ed.)pp 505–513. Academic Press, London.
4. GHOSE, K. (1980) Biochemical assessment of anti-depressive drugs. Br. J. Clin. Pharmacol., 10, 539–550.
5. ILETT, K.F., GEORGE, C.F. and DAVIES, D.S. (1980) The effect of monoamine oxidase inhibitors on first pass metabolism of tyramine in dog intestine. Biochem. Pharmacol. 29, 2551–2556.